ASH 2012: Interview with Dr. Wiestner from th... - CLL Support

CLL Support

22,510 members38,657 posts

ASH 2012: Interview with Dr. Wiestner from the NIH

bkoffman profile image
bkoffmanCLL CURE Hero
2 Replies

Friends,

Please check out my blog ( bkoffman.blogspot.com ) for the very short but insightful conclusion of my video interview with Dr. Wiestner from ASH 2012

Happy to let everyone know that I will be joining forces with my friend and long time professional journalist, patient advocate and CLL survivor, Andrew Schorr to bring you the latest news from ASCO 2013 on both Patient Power and on my blog. I am excited to be extending the reach of what information we can share without wearing out our welcome with the CLL specialists by working with Andrew and the team to bring interviews and commentaries on CLL and other cancers.

Stay strong.

Brian

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
2 Replies
jangreen profile image
jangreen

Hi whats important to remember is these videos that you and Andrew produce are our only link with these world experts. The more we have the better. Best wishes

Dave3579 profile image
Dave3579

I agree with Jan. Brian and Andrew do a lot of Good for the cause of CLL and us patients. Keep on keeping on Stay well everyone! Dave

You may also like...

ASH 2012 Interview: Dr Jeff Sharman \"Why New CLL Treatments Supersede FCR\"

with CLL getting plenty of attention lately. In the video below, Andrew Schorr of Patient Power,...

ASH 2013: INTERVIEW WITH DR. FURMAN RE: IDELALISIB

Hi friends In my last blog post ( http://bkoffman.blogspot.com ), I have a short and interesting...

My 1 year CAR-T anniversary and from ASH 2018, Dr. Siddiqi on how CLL treatment has changed.

ersary/ Also this week, I posted a brief ASH 2018 interview with Dr. Siddiqi that hits the important

Your opportunity to suggest questions for Patient Power ASH 2013 Interviews

Andrew Schorr has posted this request on the CLL ACOR List for questions to present to CLL experts...

ASH 2018: Dr. Kipps on antibodies and Venetoclax resistance

continue to work. In the first part of my interview with Dr. Kipps at ASH 2018, he discusses...